Objective: The main purpose of this retrospective study was to compare cyclin E expression levels in operable breast cancer patients determined using real-time RT-PCR and immunostaining. The prognostic relevance of cyclin E was also investigated. Methods: Specimens of invasive ductal breast cancer tissues obtained from 124 women during radical mastectomy were analyzed. Results: Of the tumor samples, 40.3 and 59.7% showed high expression of cyclin E in RT-PCR and immunostaining, respectively. The overall agreement probability was 0.032 according to Scott's π statistic. With a median follow-up of 55.5 months, cyclin E expression assessed using immunostaining was an independent negative prognostic factor in the node positive group (hazard ratio 3.1; 95% CI 1.0-9.2; P = 0.045). Cyclin E expression correlated with absence of steroid receptors and younger age. RT-PCR results did not predict survival in any group of patients. Conclusions: Disagreement between real-time RT-PCR and immunostaining was demonstrated. Immunostaining seems to be the more reliable method for assessing cyclin E in breast cancer cells. © 2006 Oxford University Press.
CITATION STYLE
Potemski, P., Pluciennik, E., Bednarek, A. K., Kusinska, R., Jesionek-Kupnicka, D., Pasz-Walczak, G., … Kordek, R. (2006). Cyclin E expression in operable breast cancer quantified using real-time RT-PCR: A comparative study with immunostaining. Japanese Journal of Clinical Oncology, 36(3), 142–149. https://doi.org/10.1093/jjco/hyi246
Mendeley helps you to discover research relevant for your work.